|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 130.63 USD | +1.82% |
|
-0.66% | +7.11% |
| 04-08 | Aptar Partners With Enable Injections for enFuse Digital Service | MT |
| 04-08 | Aptar digital health partners with Enable Injections for Enfuse® companion digital solution | RE |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 5.64 | 5.64 | 6.51 | 7.23 | 6.66 | |||||
Return on Total Capital | 7.22 | 7.17 | 8.22 | 9.04 | 8.23 | |||||
Return On Equity % | 12.7 | 11.82 | 12.95 | 15.57 | 15.1 | |||||
Return on Common Equity | 12.78 | 11.89 | 13.05 | 15.68 | 15.28 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 35.67 | 35.03 | 36.23 | 37.83 | 37.19 | |||||
SG&A Margin | 17.02 | 16.67 | 16.17 | 16.14 | 15.92 | |||||
EBITDA Margin % | 18.65 | 18.36 | 20.06 | 21.7 | 21.27 | |||||
EBITA Margin % | 12.64 | 12.64 | 14.21 | 15.56 | 14.86 | |||||
EBIT Margin % | 11.37 | 11.33 | 12.93 | 14.33 | 13.67 | |||||
Income From Continuing Operations Margin % | 7.55 | 7.21 | 8.15 | 10.44 | 10.39 | |||||
Net Income Margin % | 7.56 | 7.2 | 8.16 | 10.45 | 10.4 | |||||
Net Avail. For Common Margin % | 7.56 | 7.2 | 8.16 | 10.45 | 10.4 | |||||
Normalized Net Income Margin | 6.62 | 6.29 | 7.63 | 8.37 | 7.92 | |||||
Levered Free Cash Flow Margin | 1.64 | 6.18 | 5.14 | 8.88 | 5.45 | |||||
Unlevered Free Cash Flow Margin | 2.23 | 6.94 | 5.86 | 9.65 | 6.32 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.79 | 0.8 | 0.81 | 0.81 | 0.78 | |||||
Fixed Assets Turnover | 2.48 | 2.42 | 2.37 | 2.35 | 2.32 | |||||
Receivables Turnover (Average Receivables) | 5.08 | 4.81 | 5.02 | 5.24 | 5.08 | |||||
Inventory Turnover (Average Inventory) | 5.06 | 4.65 | 4.45 | 4.57 | 4.75 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.38 | 1.56 | 1.24 | 1.38 | 1.62 | |||||
Quick Ratio | 0.83 | 0.91 | 0.73 | 0.84 | 1.05 | |||||
Operating Cash Flow to Current Liabilities | 0.37 | 0.52 | 0.46 | 0.6 | 0.49 | |||||
Days Sales Outstanding (Average Receivables) | 71.79 | 75.83 | 72.72 | 69.79 | 71.8 | |||||
Days Outstanding Inventory (Average Inventory) | 72.16 | 78.49 | 82.05 | 80.09 | 76.9 | |||||
Average Days Payable Outstanding | 45.15 | 50.15 | 52.62 | 52.52 | 47.44 | |||||
Cash Conversion Cycle (Average Days) | 98.79 | 104.17 | 102.14 | 97.37 | 101.25 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 63.49 | 60.16 | 52.6 | 43.97 | 57.1 | |||||
Total Debt / Total Capital | 38.83 | 37.56 | 34.47 | 30.54 | 36.35 | |||||
LT Debt/Equity | 48.12 | 52.97 | 31.3 | 29.68 | 43.78 | |||||
Long-Term Debt / Total Capital | 29.43 | 33.07 | 20.51 | 20.61 | 27.87 | |||||
Total Liabilities / Total Assets | 52.08 | 50.8 | 47.86 | 43.91 | 48.37 | |||||
EBIT / Interest Expense | 12.12 | 9.22 | 11.15 | 11.7 | 9.79 | |||||
EBITDA / Interest Expense | 21.04 | 15.84 | 18.33 | 18.62 | 16.08 | |||||
(EBITDA - Capex) / Interest Expense | 10.87 | 8.23 | 10.6 | 12.33 | 10.96 | |||||
Total Debt / EBITDA | 1.98 | 1.92 | 1.65 | 1.34 | 1.83 | |||||
Net Debt / EBITDA | 1.78 | 1.71 | 1.35 | 1.06 | 1.34 | |||||
Total Debt / (EBITDA - Capex) | 3.83 | 3.7 | 2.85 | 2.02 | 2.68 | |||||
Net Debt / (EBITDA - Capex) | 3.45 | 3.28 | 2.33 | 1.6 | 1.97 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 10.17 | 2.94 | 4.97 | 2.74 | 5.42 | |||||
Gross Profit, 1 Yr. Growth % | 6.01 | 1.11 | 8.55 | 7.29 | 3.63 | |||||
EBITDA, 1 Yr. Growth % | 1.33 | 1.37 | 14.67 | 11.13 | 3.38 | |||||
EBITA, 1 Yr. Growth % | -1.3 | 2.91 | 18.04 | 12.53 | 0.65 | |||||
EBIT, 1 Yr. Growth % | -1.78 | 2.56 | 19.82 | 13.9 | 0.52 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 13.8 | -1.68 | 18.63 | 31.67 | 4.9 | |||||
Net Income, 1 Yr. Growth % | 14.04 | -1.97 | 18.89 | 31.65 | 4.87 | |||||
Normalized Net Income, 1 Yr. Growth % | 2.41 | -2.13 | 27.31 | 12.66 | -0.24 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 12.46 | -0.55 | 18.38 | 30.12 | 6.51 | |||||
Accounts Receivable, 1 Yr. Growth % | 17.85 | 0.58 | 0.31 | -3.63 | 21.59 | |||||
Inventory, 1 Yr. Growth % | 16.36 | 10.27 | 5.39 | -9.99 | 16.47 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 5.5 | 4.78 | 9.61 | -1.68 | 15.27 | |||||
Total Assets, 1 Yr. Growth % | 3.79 | 1.5 | 5.91 | -0.44 | 18.51 | |||||
Tangible Book Value, 1 Yr. Growth % | 4.17 | 25.23 | 33.77 | 20.81 | 4.22 | |||||
Common Equity, 1 Yr. Growth % | 6.43 | 4.29 | 12.31 | 7.16 | 7.94 | |||||
Cash From Operations, 1 Yr. Growth % | -36.26 | 31.69 | 20.19 | 11.85 | -11.41 | |||||
Capital Expenditures, 1 Yr. Growth % | 25.2 | 0.81 | 0.62 | -11.48 | -2.19 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -80.74 | 287.83 | -12.67 | 57.97 | -35.28 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -75.68 | 221.17 | -11.38 | 52.47 | -30.88 | |||||
Dividend Per Share, 1 Yr. Growth % | 4.17 | 1.33 | 3.95 | 8.86 | 6.4 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 6.23 | 6.5 | 3.95 | 3.85 | 4.07 | |||||
Gross Profit, 2 Yr. CAGR % | 5.22 | 3.53 | 4.51 | 7.92 | 5.45 | |||||
EBITDA, 2 Yr. CAGR % | 1.27 | 1.76 | 7.65 | 12.89 | 7.19 | |||||
EBITA, 2 Yr. CAGR % | -1.42 | 1.38 | 9.98 | 15.25 | 6.42 | |||||
EBIT, 2 Yr. CAGR % | -3.28 | 1.02 | 10.58 | 16.83 | 7 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 0.29 | 5.78 | 8 | 24.98 | 17.52 | |||||
Net Income, 2 Yr. CAGR % | 0.39 | 5.73 | 7.96 | 25.11 | 17.5 | |||||
Normalized Net Income, 2 Yr. CAGR % | -2.66 | 0.84 | 11.33 | 19.76 | 6.02 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -0.69 | 5.75 | 8.5 | 24.11 | 17.72 | |||||
Accounts Receivable, 2 Yr. CAGR % | 9.32 | 8.99 | 0.55 | -1.68 | 8.25 | |||||
Inventory, 2 Yr. CAGR % | 8.39 | 13.28 | 7.8 | -2.6 | 2.39 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 7.41 | 5.14 | 7.17 | 3.81 | 6.46 | |||||
Total Assets, 2 Yr. CAGR % | 7.82 | 2.64 | 3.68 | 2.69 | 8.62 | |||||
Tangible Book Value, 2 Yr. CAGR % | 10.6 | 14.21 | 29.43 | 27.13 | 12.21 | |||||
Common Equity, 2 Yr. CAGR % | 11.93 | 5.36 | 8.23 | 9.7 | 7.55 | |||||
Cash From Operations, 2 Yr. CAGR % | -15.95 | -8.38 | 25.81 | 15.94 | -0.46 | |||||
Capital Expenditures, 2 Yr. CAGR % | 12.74 | 12.34 | 0.71 | -5.63 | -6.95 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -53.55 | -13.08 | 82.12 | 24.52 | 1.11 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -48.17 | -11.17 | 67.41 | 22.39 | 2.65 | |||||
Dividend Per Share, 2 Yr. CAGR % | 2.78 | 2.74 | 2.63 | 6.38 | 7.62 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 5.29 | 5.12 | 5.99 | 3.55 | 4.37 | |||||
Gross Profit, 3 Yr. CAGR % | 6.54 | 3.83 | 5.18 | 5.43 | 6.47 | |||||
EBITDA, 3 Yr. CAGR % | 4.86 | 1.3 | 5.89 | 8.8 | 9.62 | |||||
EBITA, 3 Yr. CAGR % | 3.73 | 0 | 6.65 | 10.82 | 10.16 | |||||
EBIT, 3 Yr. CAGR % | 1.57 | -1.37 | 6.93 | 11.68 | 11.12 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 7.75 | -0.37 | 9.9 | 15.37 | 17.89 | |||||
Net Income, 3 Yr. CAGR % | 7.82 | -0.4 | 9.95 | 15.34 | 17.96 | |||||
Normalized Net Income, 3 Yr. CAGR % | 1.88 | -2.49 | 8.99 | 11.77 | 12.68 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 6.36 | -0.64 | 9.81 | 15.28 | 17.94 | |||||
Accounts Receivable, 3 Yr. CAGR % | 6.43 | 6.4 | 6.09 | -0.86 | 5.54 | |||||
Inventory, 3 Yr. CAGR % | 5.02 | 9.01 | 10.58 | 1.51 | 3.38 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 10.51 | 6.53 | 6.61 | 4.14 | 7.5 | |||||
Total Assets, 3 Yr. CAGR % | 7.03 | 5.67 | 3.72 | 2.29 | 7.71 | |||||
Tangible Book Value, 3 Yr. CAGR % | 11.58 | 15.28 | 20.39 | 26.49 | 18.98 | |||||
Common Equity, 3 Yr. CAGR % | 11.45 | 9.32 | 7.63 | 7.87 | 9.11 | |||||
Cash From Operations, 3 Yr. CAGR % | 5.04 | -2.38 | 0.3 | 20.97 | 6 | |||||
Capital Expenditures, 3 Yr. CAGR % | 13.38 | 8.61 | 8.29 | -3.53 | -4.5 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -25.88 | -5.77 | -12.95 | 80.58 | 0.11 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -21.82 | -4.81 | -11.24 | 67.94 | 1.16 | |||||
Dividend Per Share, 3 Yr. CAGR % | 4.35 | 2.29 | 3.14 | 4.67 | 6.38 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 6.72 | 6.11 | 4.75 | 4.61 | 5.22 | |||||
Gross Profit, 5 Yr. CAGR % | 6.64 | 6.08 | 5.83 | 5.45 | 5.29 | |||||
EBITDA, 5 Yr. CAGR % | 5.03 | 4.96 | 6.03 | 5.79 | 6.41 | |||||
EBITA, 5 Yr. CAGR % | 4.63 | 4.55 | 6.28 | 5.84 | 6.56 | |||||
EBIT, 5 Yr. CAGR % | 3.03 | 2.93 | 5.19 | 5.54 | 6.96 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 3.45 | 1.72 | 7.85 | 9.09 | 12.89 | |||||
Net Income, 5 Yr. CAGR % | 3.49 | 1.69 | 7.87 | 9.11 | 12.91 | |||||
Normalized Net Income, 5 Yr. CAGR % | 3.82 | 3.16 | 5.67 | 5.87 | 7.79 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 2.63 | 1.03 | 7.21 | 8.6 | 12.91 | |||||
Accounts Receivable, 5 Yr. CAGR % | 9.66 | 6.28 | 4.08 | 3.14 | 6.95 | |||||
Inventory, 5 Yr. CAGR % | 8.26 | 7.62 | 6.13 | 4.21 | 7.23 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 11.28 | 10.07 | 9.16 | 5.43 | 6.55 | |||||
Total Assets, 5 Yr. CAGR % | 9.7 | 6.02 | 5.68 | 4.47 | 5.65 | |||||
Tangible Book Value, 5 Yr. CAGR % | -1.19 | 0.52 | 18.4 | 19.88 | 17.05 | |||||
Common Equity, 5 Yr. CAGR % | 10.9 | 9.38 | 10.15 | 9.48 | 7.59 | |||||
Cash From Operations, 5 Yr. CAGR % | 2.24 | 8.07 | 12.9 | 4.58 | -0.01 | |||||
Capital Expenditures, 5 Yr. CAGR % | 19.01 | 14.66 | 8.13 | 2.68 | 1.91 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -23.68 | 9.04 | 6.64 | 5.34 | -5.39 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -20.51 | 7.8 | 6.35 | 5.26 | -3.97 | |||||
Dividend Per Share, 5 Yr. CAGR % | 4.22 | 3.5 | 3.66 | 3.91 | 4.91 |
- Stock Market
- Equities
- ATR Stock
- Financials AptarGroup, Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















